News | Digital Pathology | March 08, 2019

FDA Grants Breakthrough Designation to Paige.AI

Designation expedites product development and provides priority regulatory review for clinical-grade artificial intelligence in pathology

FDA Grants Breakthrough Designation to Paige.AI

March 8, 2019 — Artificial intelligence (AI) startup company Paige.AI has been granted Breakthrough Device designation by the U.S. Food and Drug Administration (FDA) for its AI designed to enhance the clinical diagnosis and treatment of cancer. It is the first such designation for AI in cancer diagnosis publicly announced by any company, according to Paige.AI.

The FDA’s Breakthrough Device designation is granted for technologies that have the potential to provide for more effective diagnosis or treatment for life-threatening or irreversibly debilitating diseases. For these technologies, timely availability is in the best interest of patients because no approved alternative exists or because the technology offers significant advantages over existing approved alternatives. The Breakthrough Device program was created by the 21st Century Cures Act.

Paige.AI was launched in early 2018 based on technology developed by company co-founder Thomas Fuchs, Ph.D., and his colleagues and a license agreement with Memorial Sloan Kettering Cancer Center (MSK). MSK began digitizing its pathology slides four years ago. Under the license agreement, Paige.AI receives de-identified images of digitized slides – more than 1 million such slides to date — and is funding the digitization of an additional 4 million archive slides, which in total will create the largest digital pathology dataset. Paige.AI is working with this de-identified dataset to develop a comprehensive portfolio of AI products across cancer subtypes to serve the needs of pathologists around the world.

For more information: www.paige.ai

Related Content

The RIS market is expected to reach $979.1 M by 2025

Image courtesy of Agfa

News | Information Technology | December 13, 2019
December 13, 2019 — According to a new study released by Rese...
Schematic diagram of the proposed multichannel deep neural network model analyzing multiscale functional brain connectome for a classification task. rsfMRI = resting-state functional MRI.

Schematic diagram of the proposed multichannel deep neural network model analyzing multiscale functional brain connectome for a classification task. rsfMRI = resting-state functional MRI. Graphic courtesy of the Radiological Society of North America.

News | Artificial Intelligence | December 11, 2019
December 11, 2019 — Deep learning, a type of arti...
EMR patient portal on a smartphone
News | Electronic Medical Records (EMR) | December 11, 2019
December 11, 2019 — Despite the numerous benefits associated with patients accessing their medical records, a new stu
#RSNA19 A sophisticated type of artificial intelligence (AI) can detect clinically meaningful chest X-ray findings as effectively as experienced radiologists, according to a study published in the journal Radiology.

Image courtesy of GE Healthcare

News | Artificial Intelligence | December 03, 2019
December 3, 2019 — A sophisticated type of...
REiLI AI platform auto segmentation.
News | Artificial Intelligence | November 30, 2019
December 1, 2019 — Fujifilm Medical Systems U.S.A.
#RSNA19 Dynamics enables a radiologist to compare X-rays and provide automatically generated reports specifically addressing the changes in images over the course of patient treatment. Initially Dynamics feature will support longitudinal comparison for pneumothorax, consolidation, mass, nodule, pleural effusion, pulmonary edema and lung congestion radiological findings where progress reports are of greatest importance
News | Artificial Intelligence | November 29, 2019
November 29, 2019 — At RSNA19 Oxipit will offer a first public p
XACT Robotics is advancing the field of radiology, pioneering the first hands-free robotic system, combining image-based planning and navigation with instrument insertion and steering capabilities
News | Artificial Intelligence | November 26, 2019
November 26, 2019 — XACT Robotics Ltd.